Efficacy of elemental diet (Elental) on diarrhea in patients with gynecologic malignancies treated with pelvic radiotherapy

Efficacy of elemental diet (Elental) on diarrhea in patients with gynecologic malignancies treated with pelvic radiotherapy - Efficacy of elemental diet (Elental) on diarrhea in patients treated with pelvic radiotherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000018205

Enrollment

Registered

2015-07-10

Start date

2014-12-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with gynecologic malignancies treated with pelvic radiotherapy

Interventions

The group administered on Erental

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: (1) The patients who receive pelvic radiotherapy against gynecologic malignancies. (2)The patients who is more than twenty years old. (3) The patients who obtain informed consent.

Exclusion criteria

Exclusion criteria: (1) The patients who has a history of gastrointestinal surgery. (2) The patients who has severe disorders of liver and kidney. (3)The patients who has uncontrolled diabetes. (4) the patients who has a history of another elemental diet. (5)The patients who has a history of Erental intake with 1 month. (6) The patients who is not suitable for this study by doctors.

Design outcomes

Primary

Measure	Time frame
diarrhea (duration or grade) during radiotherapy	—

Countries

Japan

Contacts

Public ContactFumiaki ISOHASHI

Osaka University Graduate School of Medicine Department of Radiation Oncology

isohashi@radonc.med.osaka-u.ac.jp06-6879-3482

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026